Sequent Scientific Limited has reported Consolidated financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 368.4050 crores during the period ended March 31, 2023 as compared to Rs. 378.1760 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. -93.5749 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. -8.8690 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. -3.77 for the period ended March 31, 2023 as compared to Rs. -0.36 for the period ended December 31, 2022.
Total Income | ₹368.4050 crs | ₹378.1760 crs | -2.58% |
Net Profit | ₹-93.5749 crs | ₹-8.8690 crs | 955.08% |
EPS | ₹-3.77 | ₹-0.36 | 947.22% |
Financial Results (Q4 FY2023) - YoY Comparison The company has reported total income of Rs.368.4050 crores during the period ended March 31, 2023 as compared to Rs.387.4790 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.-93.5749 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.8.8260 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.-3.77 for the period ended March 31, 2023 as compared to Rs.0.34 for the period ended March 31, 2022.
Total Income | ₹368.4050 crs | ₹387.4790 crs | -4.92% |
Net Profit | ₹-93.5749 crs | ₹8.8260 crs | -1,160.22% |
EPS | ₹-3.77 | ₹0.34 | -1,208.82% |
Financial Results (Year Ended FY2023) - YoY Comparison The company has reported total income of Rs.1427.2990 crores during the Financial Year ended March 31, 2023 as compared to Rs.1423.6610 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.-121.1599 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.40.9550 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.-4.88 for the Financial Year ended March 31, 2023 as compared to Rs.1.63 for the Financial Year ended March 31, 2022.
Total Income | ₹1427.2990 crs | ₹1423.6610 crs | 0.26% |
Net Profit | ₹-121.1599 crs | ₹40.9550 crs | -395.84% |
EPS | ₹-4.88 | ₹1.63 | -399.39% |
Shares of Sequent Scientific Limited was last trading in BSE at Rs. 77.39 as compared to the previous close of Rs. 78.95. The total number of shares traded during the day was 23506 in over 346 trades.
The stock hit an intraday high of Rs. 79.33 and intraday low of 76.85. The net turnover during the day was Rs. 1838541.00.
Source : Equity Bulls
Keywords
SequentScientific
Q4FY23
FY2023
ResultUpdate